This review explores the current state of HIV/AIDS treatment, emphasizing the need for alternative approaches beyond antiretroviral therapy (ART). ART, while effective in controlling HIV, has limitations such as drug resistance, side effects, and accessibility issues. The review highlights emerging treatment modalities including stem cell transplantation, immunotherapy, gene therapy, latency reversal agents (LRAs), and pharmaceutical vaccines. These approaches aim to achieve long-term viral control or even a cure by targeting HIV reservoirs, enhancing immune responses, and modifying host cells to resist infection. Gene therapy, particularly using CRISPR/Cas9, shows promise in editing HIV-infected cells and modifying host cells to prevent infection. LRAs aim to reactivate latent HIV, making it vulnerable to immune attack or antiretroviral drugs. Vaccines are being developed to boost the immune system's ability to combat HIV. Stem cell transplantation, while promising, faces challenges related to donor availability and safety. The review underscores the importance of ongoing research and innovation to overcome current barriers and achieve a cure for HIV/AIDS. Despite progress, challenges such as drug resistance, viral reservoirs, and accessibility remain significant. The article emphasizes the need for continued investment in research, collaboration, and the development of safe and effective treatments to end the HIV/AIDS pandemic.This review explores the current state of HIV/AIDS treatment, emphasizing the need for alternative approaches beyond antiretroviral therapy (ART). ART, while effective in controlling HIV, has limitations such as drug resistance, side effects, and accessibility issues. The review highlights emerging treatment modalities including stem cell transplantation, immunotherapy, gene therapy, latency reversal agents (LRAs), and pharmaceutical vaccines. These approaches aim to achieve long-term viral control or even a cure by targeting HIV reservoirs, enhancing immune responses, and modifying host cells to resist infection. Gene therapy, particularly using CRISPR/Cas9, shows promise in editing HIV-infected cells and modifying host cells to prevent infection. LRAs aim to reactivate latent HIV, making it vulnerable to immune attack or antiretroviral drugs. Vaccines are being developed to boost the immune system's ability to combat HIV. Stem cell transplantation, while promising, faces challenges related to donor availability and safety. The review underscores the importance of ongoing research and innovation to overcome current barriers and achieve a cure for HIV/AIDS. Despite progress, challenges such as drug resistance, viral reservoirs, and accessibility remain significant. The article emphasizes the need for continued investment in research, collaboration, and the development of safe and effective treatments to end the HIV/AIDS pandemic.